Medtronic Inc (MDT.N)
49.84USD
17 May 2013
$0.20 (+0.40%)
$49.64
$49.59
$49.84
$49.27
2,853,009
1,232,399
$50.16
$35.68
MDT.N
About
Overall
| Beta: | 0.93 |
| Market Cap (Mil.): | $50,528.09 |
| Shares Outstanding (Mil.): | 1,013.81 |
| Dividend: | 0.26 |
| Yield (%): | 2.09 |
Financials
| MDT.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 15.21 | 30.63 | 35.83 |
| EPS (TTM): | 3.28 | -- | -- |
| ROI: | 12.24 | 10.42 | 18.72 |
| ROE: | 19.35 | 13.40 | 19.54 |
REFILE-BRIEF-Medtronic says FDA approves longer lengths of Resolute Integrity stent
Feb 25 - Feb 25 - Medtronic Inc : * FDA approves longer lengths of medtronic's resolute integrity stent * FDA approved 34mm,38mm lengths of resolute integrity drug-eluting stent in
Medtronic profit up; shares fall on weak demand in Europe
- Medtronic Inc reported higher quarterly earnings on Tuesday, but sales of key heart and spine devices fell and overall European sales weakened in January, sending the company's shares down nearly 3 percent.
UPDATE 3-Medtronic profit up; shares fall on weak demand in Europe
Feb 19 - Medtronic Inc reported higher quarterly earnings on Tuesday, but sales of key heart and spine devices fell and overall European sales weakened in January, sending the company's shares down nearly 3 percent.
BRIEF-Medtronic down 0.9 percent in premarket trading
NEW YORK, Feb 19 - Medtronic Inc : * Shares down 0.9 percent in premarket trading
Medtronic posts higher-than-expected quarterly earnings
Feb 19 - Medtronic Inc on Tuesday reported higher quarterly earnings as sales rose slightly.
Medtronic sees fiscal 2013 EPS up 6-7 percent
- Medical device maker Medtronic Inc said on Monday that fiscal 2013 earnings will be at the upper end of its previously forecast range, boosted by a research tax credit, for an annual growth rate of 6 percent to 7 percent.
UPDATE 1-Medtronic sees fiscal 2013 EPS up 6-7 percent
Jan 7 - Medical device maker Medtronic Inc said on Monday that fiscal 2013 earnings will be at the upper end of its previously forecast range, boosted by a research tax credit, for an annual growth rate of 6 percent to 7 percent.
Medtronic narrows forecast for FY 2013 earnings
Jan 7 - Medical device maker Medtronic Inc said on Monday that fiscal 2013 earnings will be at the upper end of its previously forecast range, boosted by a research tax credit.
Medtronic, Pew urge quick adoption of medical 'sunshine' rule
* Rule requires disclosure of manufacturers' ties to doctors, hospitals
Medtronic shares jump on signs its markets are improving
- Medtronic Inc , the world's largest maker of medical devices, reported lower quarterly earnings as legal and other expenses ate into profits, but signs that its key heart and spine markets were stabilizing sent its shares higher on Tuesday.
Competitors
| Price | Change | |
|---|---|---|
| Olympus Corp (7733.T) | ¥3,185 | -30.00 |
| General Electric Company (GE.N) | $23.46 | +0.19 |
| Siemens AG (SIEGn.DE) | €80.87 | -0.01 |
| Johnson & Johnson (JNJ.N) | $88.09 | +0.64 |
| Roche Holding Ltd. (ROG.VX) | CHF247.00 | +1.00 |
| Abbott Laboratories (ABT.N) | $36.59 | -0.24 |
| Koninklijke Philips Electronics NV (PHG.AS) | €22.27 | -0.24 |
| Covidien plc (COV.N) | $65.77 | +0.10 |
| Stryker Corporation (SYK.N) | $68.90 | -0.16 |
| Boston Scientific Corporation (BSX.N) | $9.10 | +0.06 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (MDT). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
